Showing 681-700 of 7110 for: Cochrane Systematic Reviews Back
- Anti-vascular endothelial growth factor for diabetic macular oedema
Cochrane Systematic Reviews, 20-Oct-2014
Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy. Although grid or focal laser photocoagulation has been shown to reduce the risk of visual loss in DMO, or clinically significant macular oedema (CSMO), vision is rarely improv
- Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion
Cochrane Systematic Reviews, 26-Nov-2012
Branch retinal vein occlusion (BRVO) is one of the most common occurring retinal vascular abnormalities. The pathogenesis of BRVO is thought to involve both retinal vein compression and damage to the vessel wall, possibly leading to thrombus formation at
- Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion
Cochrane Systematic Reviews, 1-May-2014
Central retinal vein occlusion (CRVO) is a relatively common retinal vascular disorder in which macular oedema may develop, with a consequent reduction in visual acuity. Until recently there has been no treatment of proven benefit, but growing evidence su
- Anti-vascular endothelial growth factor for neovascular age-related macular degeneration
Cochrane Systematic Reviews, 29-Aug-2014
Age-related macular degeneration (AMD) is the most common cause of uncorrectable severe vision loss in people aged 55 years and older in the developed world. Choroidal neovascularization (CNV) secondary to neovascular AMD accounts for most AMD-related sev
- Anti-vascular endothelial growth factor for neovascular glaucoma
Cochrane Systematic Reviews, 12-Sep-2013
Neovascular glaucoma (NVG) is a potentially blinding secondary glaucoma. It is caused by the formation of abnormal new blood vessels which prevent normal drainage of aqueous from the anterior segment of the eye. Anti-vascular endothelial growth factor (an
- Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy
Cochrane Systematic Reviews, 6-Aug-2015
Postoperative vitreous cavity haemorrhage (POVCH) is a significant complication following vitrectomy for proliferative diabetic retinopathy (PDR). It delays visual recovery and can make further treatment difficult if the view of the fundus is significantl
- Anti-vascular endothelial growth factor for proliferative diabetic retinopathy
Cochrane Systematic Reviews, 25-Nov-2014
Proliferative diabetic retinopathy (PDR) is a complication of diabetic retinopathy that can cause blindness. Although panretinal photocoagulation (PRP) is the treatment of choice for PDR, it has secondary effects that can affect vision. An alternative tre
- Antiviral agents for treatment of herpes simplex virus infection in neonates
Cochrane Systematic Reviews, 12-May-2009
Herpes simplex virus (HSV) is a rare but serious neonatal pathogen. Prior to the availability of antiviral drugs the mortality associated with all but localised neonatal infection was high, with 85% of infants with disseminated HSV infection and 50% of in
- Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virus
Cochrane Systematic Reviews, 3-Sep-2014
Antiviral therapy for recurrent hepatitis C infection after liver transplantation is controversial due to unresolved balance between benefits and harms.
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
Cochrane Systematic Reviews, 10-Jan-2013
The risk of cytomegalovirus (CMV) infection in solid organ transplant recipients has resulted in the frequent use of prophylaxis with the aim of preventing the clinical syndrome associated with CMV infection. This is an update of a review first published
- Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantation
Cochrane Systematic Reviews, 28-Nov-2013
It is not clear whether prophylactic antiviral therapy is indicated to improve patient and graft survival in patients undergoing liver transplantation for chronic decompensated hepatitis C virus (HCV) infection.
- Antiviral therapy for Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults
Cochrane Systematic Reviews, 5-Nov-2008
Herpes zoster oticus (HZO) is a viral infection of the ear and when associated with acute facial paralysis is known as Ramsay Hunt syndrome. Antiviral agents are the standard first-line treatment for herpes zoster infections at other body sites and are th
- Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis
Cochrane Systematic Reviews, 9-Jan-2015
Eye disease due to herpes simplex virus (HSV) commonly presents as epithelial keratitis which, though usually self-limiting, may persist or progress without treatment.
- Antiviral treatment for Bell's palsy (idiopathic facial paralysis)
Cochrane Systematic Reviews, 29-Oct-2015
Corticosteroids are widely used in the treatment of idiopathic facial paralysis (Bell’s palsy), but the effectiveness of additional treatment with an antiviral agent is uncertain. Significant morbidity can be associated with severe cases of Bell's palsy.
- Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus
Cochrane Systematic Reviews, 16-Feb-2010
Antiviral treatment for chronic hepatitis C may be less effective if patients are co-infected with human immunodeficiency virus (HIV).
- Antiviral treatment for preventing postherpetic neuralgia
Cochrane Systematic Reviews, 26-Jan-2014
Postherpetic neuralgia (PHN) is a painful and refractory complication of herpes zoster. Treatments are either partially or totally ineffective for many people with PHN. Antiviral agents, used at the time of the rash, have been proposed as an intervention
- Antivirals for idiopathic sudden sensorineural hearing loss
Cochrane Systematic Reviews, 6-Jul-2012
Idiopathic sudden sensorineural hearing loss (ISSHL) is characterised by sudden loss of hearing of cochlear or retro-cochlear origin without an identifiable cause. Antivirals are commonly prescribed, but there is no consensus on the treatment regimen or t
- Antivirals for the common cold
Cochrane Systematic Reviews, 16-Jun-2008
The common cold is a ubiquitous short and usually mild illness for which preventive and treatment interventions have been under development since the mid-40s. As our understanding of the disease has increased, more experimental antivirals have been develo
- Anxiolytics for smoking cessation
Cochrane Systematic Reviews, 21-Jun-2011
There are two reasons to believe anxiolytics might help in smoking cessation. Anxiety may be a symptom of nicotine withdrawal. Secondly, smoking could be due to an attempt to self-medicate an anxiety problem.
- Appendectomy versus antibiotic treatment for acute appendicitis
Cochrane Systematic Reviews, 4-Oct-2011
Acute appendicitis is one of the most common causes of acute abdominal pain. Present day treatment of choice for acute appendicitis is appendectomy, however complications are inherent to operative treatment. Though surgical appendectomy remains the standa
